Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Arbutus Biopharma Corp (NASDAQ:ABUS)

3.13
Delayed Data
As of 4:00pm ET
 -0.04 / -1.26%
Today’s Change
2.96
Today|||52-Week Range
23.95
-29.66%
Year-to-Date
No recent news for Arbutus Biopharma Corp.

Today’s Trading

Previous close3.17
Today’s open3.17
Day’s range3.06 - 3.21
Volume186,560
Average volume (3 months)333,034
Market cap$173.0M
Dividend yield--
Data as of 4:00pm ET, 02/05/2016

Growth & Valuation

Earnings growth (last year)-95.65%
Earnings growth (this year)--
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-3.31%
P/E ratio--
Price/Sales22.17
Price/Book0.81

Competitors

 Today’s
change
Today’s
% change
AGRXAgile Therapeutics I...-0.46-7.40%
NBRVNabriva Therapeutics...+0.04+0.48%
CYNACynapsus Therapeutic...-0.04-0.29%
LPCNLipocine Inc-0.05-0.55%
Data as of 4:00pm ET, 02/05/2016

Financials

Next reporting dateMarch 16, 2016
EPS forecast (this quarter)-$0.40
Annual revenue (last year)$15.0M
Annual profit (last year)-$38.8M
Net profit margin-259.73%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark J. Murray
Chief Operating &
Business Officer
Patrick T. Higgins
Corporate headquarters
Burnaby, British Columbia

Forecasts

Partner Offers